HEADER HORMONE RECEPTOR 25-JUN-14 4TV1 TITLE CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH PROPYLPARABEN COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 302-552; COMPND 5 SYNONYM: ER,ER-ALPHA,ESTRADIOL RECEPTOR,NUCLEAR RECEPTOR SUBFAMILY 3 COMPND 6 GROUP A MEMBER 1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: ESTROGEN RECEPTOR; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: RESIDUES 302-552; COMPND 13 SYNONYM: ER,ER-ALPHA,ESTRADIOL RECEPTOR,NUCLEAR RECEPTOR SUBFAMILY 3 COMPND 14 GROUP A MEMBER 1; COMPND 15 ENGINEERED: YES; COMPND 16 MOL_ID: 3; COMPND 17 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 1; COMPND 18 CHAIN: C, D; COMPND 19 FRAGMENT: RESIDUES 686-698; COMPND 20 SYNONYM: NCOA-1,CLASS E BASIC HELIX-LOOP-HELIX PROTEIN 74,BHLHE74, COMPND 21 PROTEIN HIN-2,RIP160,RENAL CARCINOMA ANTIGEN NY-REN-52,STEROID COMPND 22 RECEPTOR COACTIVATOR 1,SRC-1, COACTIVATOR PEPTIDE SRC-1; COMPND 23 EC: 2.3.1.48; COMPND 24 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ESR1, ESR, NR3A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: ESR1, ESR, NR3A1; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 21 MOL_ID: 3; SOURCE 22 SYNTHETIC: YES; SOURCE 23 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 24 ORGANISM_COMMON: HUMAN; SOURCE 25 ORGANISM_TAXID: 9606 KEYWDS NUCLEAR HORMONE RECEPTOR, LIGAND BINDING DOMAIN, ENDOCRINE DISRUPTOR, KEYWDS 2 ENVIRONMENTAL COMPOUND, HORMONE RECEPTOR EXPDTA X-RAY DIFFRACTION AUTHOR V.DELFOSSE,M.GRIMALDI,W.BOURGUET REVDAT 3 23-OCT-24 4TV1 1 REMARK REVDAT 2 20-DEC-23 4TV1 1 REMARK REVDAT 1 28-JAN-15 4TV1 0 JRNL AUTH V.DELFOSSE,A.L.MAIRE,P.BALAGUER,W.BOURGUET JRNL TITL A STRUCTURAL PERSPECTIVE ON NUCLEAR RECEPTORS AS TARGETS OF JRNL TITL 2 ENVIRONMENTAL COMPOUNDS. JRNL REF ACTA PHARMACOL.SIN. V. 36 88 2015 JRNL REFN ESSN 1745-7254 JRNL PMID 25500867 JRNL DOI 10.1038/APS.2014.133 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.6.4_486) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.57 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.010 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 43551 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.169 REMARK 3 R VALUE (WORKING SET) : 0.167 REMARK 3 FREE R VALUE : 0.202 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2177 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 27.5720 - 4.6547 0.98 2596 137 0.1841 0.2058 REMARK 3 2 4.6547 - 3.6974 1.00 2608 137 0.1415 0.1663 REMARK 3 3 3.6974 - 3.2308 1.00 2599 137 0.1563 0.1834 REMARK 3 4 3.2308 - 2.9358 1.00 2609 137 0.1672 0.2107 REMARK 3 5 2.9358 - 2.7256 1.00 2593 136 0.1662 0.2107 REMARK 3 6 2.7256 - 2.5650 1.00 2586 137 0.1672 0.1800 REMARK 3 7 2.5650 - 2.4366 1.00 2561 134 0.1632 0.2263 REMARK 3 8 2.4366 - 2.3306 1.00 2579 136 0.1673 0.1974 REMARK 3 9 2.3306 - 2.2409 1.00 2590 137 0.1704 0.2080 REMARK 3 10 2.2409 - 2.1636 1.00 2603 137 0.1699 0.2090 REMARK 3 11 2.1636 - 2.0960 1.00 2582 135 0.1727 0.2330 REMARK 3 12 2.0960 - 2.0361 1.00 2596 136 0.1788 0.2242 REMARK 3 13 2.0361 - 1.9825 1.00 2569 135 0.1799 0.2419 REMARK 3 14 1.9825 - 1.9342 1.00 2568 135 0.1847 0.2459 REMARK 3 15 1.9342 - 1.8902 1.00 2584 137 0.1946 0.2493 REMARK 3 16 1.8902 - 1.8500 1.00 2551 134 0.2108 0.2462 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.20 REMARK 3 SHRINKAGE RADIUS : 0.95 REMARK 3 K_SOL : 0.36 REMARK 3 B_SOL : 45.40 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.190 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.970 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.97900 REMARK 3 B22 (A**2) : 1.20030 REMARK 3 B33 (A**2) : 0.77880 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 4.29750 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 4099 REMARK 3 ANGLE : 0.966 5562 REMARK 3 CHIRALITY : 0.064 657 REMARK 3 PLANARITY : 0.003 690 REMARK 3 DIHEDRAL : 18.342 1546 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4TV1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 25-JUN-14. REMARK 100 THE DEPOSITION ID IS D_1000202313. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-JUN-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.75 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.07231 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43567 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 46.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 7.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06000 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 20.5300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.96 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 7.40 REMARK 200 R MERGE FOR SHELL (I) : 0.41000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX (PHENIX.REFINE: 1.6.4_486) REMARK 200 STARTING MODEL: 3UUD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.65 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 300-340 MM NACL, 100 MM HEPES, 24-32 % REMARK 280 PEG 3350, PH 7.75, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 42.03000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7440 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18920 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 302 REMARK 465 LYS A 303 REMARK 465 ASN A 304 REMARK 465 LEU A 462 REMARK 465 SER A 463 REMARK 465 SER A 464 REMARK 465 THR A 465 REMARK 465 LEU A 466 REMARK 465 LYS A 467 REMARK 465 SER A 468 REMARK 465 LEU A 469 REMARK 465 LEU A 549 REMARK 465 HIS A 550 REMARK 465 ALA A 551 REMARK 465 PRO A 552 REMARK 465 LYS B 302 REMARK 465 LYS B 303 REMARK 465 ASN B 304 REMARK 465 SER B 305 REMARK 465 PRO B 336 REMARK 465 LEU B 462 REMARK 465 SER B 463 REMARK 465 SER B 464 REMARK 465 THR B 465 REMARK 465 LEU B 466 REMARK 465 LYS B 467 REMARK 465 SER B 468 REMARK 465 LEU B 469 REMARK 465 GLU B 470 REMARK 465 LEU B 549 REMARK 465 HIS B 550 REMARK 465 ALA B 551 REMARK 465 PRO B 552 REMARK 465 ARG C 686 REMARK 465 HIS C 687 REMARK 465 GLY C 697 REMARK 465 SER C 698 REMARK 465 ARG D 686 REMARK 465 HIS D 687 REMARK 465 GLY D 697 REMARK 465 SER D 698 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 305 OG REMARK 470 LEU A 306 CG CD1 CD2 REMARK 470 SER A 309 OG REMARK 470 ARG A 335 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 470 CG CD OE1 OE2 REMARK 470 GLU A 471 CG CD OE1 OE2 REMARK 470 LYS A 472 CG CD CE NZ REMARK 470 LYS A 492 CG CD CE NZ REMARK 470 ASP A 545 OD1 OD2 REMARK 470 ARG A 548 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 306 CG CD1 CD2 REMARK 470 ARG B 335 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 419 CG CD OE1 OE2 REMARK 470 GLU B 471 CG CD OE1 OE2 REMARK 470 LYS B 472 CG CD CE NZ REMARK 470 ASP B 473 CG OD1 OD2 REMARK 470 LYS B 492 NZ REMARK 470 LYS B 529 NZ REMARK 470 LYS B 531 CG CD CE NZ REMARK 470 VAL B 533 CG1 CG2 REMARK 470 ARG B 548 CG CD NE CZ NH1 NH2 REMARK 470 LYS C 688 CG CD CE NZ REMARK 470 LYS D 688 CG CD CE NZ REMARK 470 ARG D 692 CG CD NE CZ NH1 NH2 REMARK 470 GLU D 696 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN B 532 76.07 -36.34 REMARK 500 VAL B 533 -65.93 -126.03 REMARK 500 GLN D 695 -63.93 -94.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 36M A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 604 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 605 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PEG A 606 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 607 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 36M B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PEG B 604 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4MG9 RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH BUTYLPARABEN. DBREF 4TV1 A 302 552 UNP P03372 ESR1_HUMAN 302 552 DBREF 4TV1 B 302 552 UNP P03372 ESR1_HUMAN 302 552 DBREF 4TV1 C 686 698 PDB 4TV1 4TV1 686 698 DBREF 4TV1 D 686 698 PDB 4TV1 4TV1 686 698 SEQADV 4TV1 SER A 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQADV 4TV1 SER B 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQRES 1 A 251 LYS LYS ASN SER LEU ALA LEU SER LEU THR ALA ASP GLN SEQRES 2 A 251 MET VAL SER ALA LEU LEU ASP ALA GLU PRO PRO ILE LEU SEQRES 3 A 251 TYR SER GLU TYR ASP PRO THR ARG PRO PHE SER GLU ALA SEQRES 4 A 251 SER MET MET GLY LEU LEU THR ASN LEU ALA ASP ARG GLU SEQRES 5 A 251 LEU VAL HIS MET ILE ASN TRP ALA LYS ARG VAL PRO GLY SEQRES 6 A 251 PHE VAL ASP LEU THR LEU HIS ASP GLN VAL HIS LEU LEU SEQRES 7 A 251 GLU CSO ALA TRP LEU GLU ILE LEU MET ILE GLY LEU VAL SEQRES 8 A 251 TRP ARG SER MET GLU HIS PRO GLY LYS LEU LEU PHE ALA SEQRES 9 A 251 PRO ASN LEU LEU LEU ASP ARG ASN GLN GLY LYS CSO VAL SEQRES 10 A 251 GLU GLY MET VAL GLU ILE PHE ASP MET LEU LEU ALA THR SEQRES 11 A 251 SER SER ARG PHE ARG MET MET ASN LEU GLN GLY GLU GLU SEQRES 12 A 251 PHE VAL CYS LEU LYS SER ILE ILE LEU LEU ASN SER GLY SEQRES 13 A 251 VAL TYR THR PHE LEU SER SER THR LEU LYS SER LEU GLU SEQRES 14 A 251 GLU LYS ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE THR SEQRES 15 A 251 ASP THR LEU ILE HIS LEU MET ALA LYS ALA GLY LEU THR SEQRES 16 A 251 LEU GLN GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU SEQRES 17 A 251 ILE LEU SER HIS ILE ARG HIS MET SER ASN LYS GLY MET SEQRES 18 A 251 GLU HIS LEU TYR SER MET LYS CSO LYS ASN VAL VAL PRO SEQRES 19 A 251 LEU SER ASP LEU LEU LEU GLU MET LEU ASP ALA HIS ARG SEQRES 20 A 251 LEU HIS ALA PRO SEQRES 1 B 251 LYS LYS ASN SER LEU ALA LEU SER LEU THR ALA ASP GLN SEQRES 2 B 251 MET VAL SER ALA LEU LEU ASP ALA GLU PRO PRO ILE LEU SEQRES 3 B 251 TYR SER GLU TYR ASP PRO THR ARG PRO PHE SER GLU ALA SEQRES 4 B 251 SER MET MET GLY LEU LEU THR ASN LEU ALA ASP ARG GLU SEQRES 5 B 251 LEU VAL HIS MET ILE ASN TRP ALA LYS ARG VAL PRO GLY SEQRES 6 B 251 PHE VAL ASP LEU THR LEU HIS ASP GLN VAL HIS LEU LEU SEQRES 7 B 251 GLU CSO ALA TRP LEU GLU ILE LEU MET ILE GLY LEU VAL SEQRES 8 B 251 TRP ARG SER MET GLU HIS PRO GLY LYS LEU LEU PHE ALA SEQRES 9 B 251 PRO ASN LEU LEU LEU ASP ARG ASN GLN GLY LYS CSO VAL SEQRES 10 B 251 GLU GLY MET VAL GLU ILE PHE ASP MET LEU LEU ALA THR SEQRES 11 B 251 SER SER ARG PHE ARG MET MET ASN LEU GLN GLY GLU GLU SEQRES 12 B 251 PHE VAL CYS LEU LYS SER ILE ILE LEU LEU ASN SER GLY SEQRES 13 B 251 VAL TYR THR PHE LEU SER SER THR LEU LYS SER LEU GLU SEQRES 14 B 251 GLU LYS ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE THR SEQRES 15 B 251 ASP THR LEU ILE HIS LEU MET ALA LYS ALA GLY LEU THR SEQRES 16 B 251 LEU GLN GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU SEQRES 17 B 251 ILE LEU SER HIS ILE ARG HIS MET SER ASN LYS GLY MET SEQRES 18 B 251 GLU HIS LEU TYR SER MET LYS CYS LYS ASN VAL VAL PRO SEQRES 19 B 251 LEU SER ASP LEU LEU LEU GLU MET LEU ASP ALA HIS ARG SEQRES 20 B 251 LEU HIS ALA PRO SEQRES 1 C 13 ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN GLU GLY SER SEQRES 1 D 13 ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN GLU GLY SER MODRES 4TV1 CSO A 381 CYS MODIFIED RESIDUE MODRES 4TV1 CSO A 417 CYS MODIFIED RESIDUE MODRES 4TV1 CSO A 530 CYS MODIFIED RESIDUE MODRES 4TV1 CSO B 381 CYS MODIFIED RESIDUE MODRES 4TV1 CSO B 417 CYS MODIFIED RESIDUE HET CSO A 381 11 HET CSO A 417 11 HET CSO A 530 7 HET CSO B 381 11 HET CSO B 417 7 HET 36M A 601 13 HET GOL A 602 6 HET GOL A 603 6 HET EDO A 604 4 HET EDO A 605 4 HET PEG A 606 7 HET GOL A 607 6 HET 36M B 601 13 HET GOL B 602 6 HET GOL B 603 6 HET PEG B 604 7 HETNAM CSO S-HYDROXYCYSTEINE HETNAM 36M PROPYL 4-HYDROXYBENZOATE HETNAM GOL GLYCEROL HETNAM EDO 1,2-ETHANEDIOL HETNAM PEG DI(HYDROXYETHYL)ETHER HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 1 CSO 5(C3 H7 N O3 S) FORMUL 5 36M 2(C10 H12 O3) FORMUL 6 GOL 5(C3 H8 O3) FORMUL 8 EDO 2(C2 H6 O2) FORMUL 10 PEG 2(C4 H10 O3) FORMUL 16 HOH *273(H2 O) HELIX 1 AA1 LEU A 306 LEU A 310 5 5 HELIX 2 AA2 THR A 311 GLU A 323 1 13 HELIX 3 AA3 SER A 338 LYS A 362 1 25 HELIX 4 AA4 GLY A 366 LEU A 370 5 5 HELIX 5 AA5 THR A 371 MET A 396 1 26 HELIX 6 AA6 ARG A 412 LYS A 416 1 5 HELIX 7 AA7 GLY A 420 ASN A 439 1 20 HELIX 8 AA8 GLN A 441 SER A 456 1 16 HELIX 9 AA9 GLY A 457 PHE A 461 5 5 HELIX 10 AB1 GLU A 471 ALA A 493 1 23 HELIX 11 AB2 THR A 496 LYS A 531 1 36 HELIX 12 AB3 SER A 537 ALA A 546 1 10 HELIX 13 AB4 HIS A 547 ARG A 548 5 2 HELIX 14 AB5 LEU B 306 LEU B 310 5 5 HELIX 15 AB6 THR B 311 GLU B 323 1 13 HELIX 16 AB7 SER B 338 VAL B 364 1 27 HELIX 17 AB8 GLY B 366 LEU B 370 5 5 HELIX 18 AB9 THR B 371 MET B 396 1 26 HELIX 19 AC1 ASN B 413 VAL B 418 5 6 HELIX 20 AC2 GLY B 420 ASN B 439 1 20 HELIX 21 AC3 GLN B 441 SER B 456 1 16 HELIX 22 AC4 GLY B 457 PHE B 461 5 5 HELIX 23 AC5 LYS B 472 ALA B 493 1 22 HELIX 24 AC6 THR B 496 LYS B 531 1 36 HELIX 25 AC7 SER B 537 ALA B 546 1 10 HELIX 26 AC8 ILE C 689 LEU C 694 1 6 HELIX 27 AC9 ILE D 689 GLU D 696 1 8 SHEET 1 AA1 2 LYS A 401 ALA A 405 0 SHEET 2 AA1 2 LEU A 408 ASP A 411 -1 O LEU A 410 N LEU A 402 SHEET 1 AA2 2 LYS B 401 ALA B 405 0 SHEET 2 AA2 2 LEU B 408 ASP B 411 -1 O LEU B 410 N LEU B 402 LINK C GLU A 380 N CSO A 381 1555 1555 1.32 LINK C CSO A 381 N ALA A 382 1555 1555 1.33 LINK C LYS A 416 N CSO A 417 1555 1555 1.33 LINK C CSO A 417 N VAL A 418 1555 1555 1.33 LINK C LYS A 529 N CSO A 530 1555 1555 1.33 LINK C CSO A 530 N LYS A 531 1555 1555 1.33 LINK C GLU B 380 N CSO B 381 1555 1555 1.33 LINK C CSO B 381 N ALA B 382 1555 1555 1.33 LINK C LYS B 416 N CSO B 417 1555 1555 1.33 LINK C CSO B 417 N VAL B 418 1555 1555 1.33 CISPEP 1 SER A 305 LEU A 306 0 -4.24 SITE 1 AC1 3 GLU A 353 LEU A 387 ARG A 394 SITE 1 AC2 6 TYR A 331 ASN A 407 LEU A 408 LEU A 409 SITE 2 AC2 6 GLN A 414 HOH A 798 SITE 1 AC3 3 GLU A 323 TRP A 393 GLY A 442 SITE 1 AC4 5 GLU A 419 GLY A 420 VAL A 422 GLU A 423 SITE 2 AC4 5 HOH A 746 SITE 1 AC5 3 TYR A 526 HIS A 547 ARG A 548 SITE 1 AC6 6 MET A 438 ASN A 439 GLN A 441 GLU A 444 SITE 2 AC6 6 MET A 490 ALA A 493 SITE 1 AC7 8 LYS A 529 ASN A 532 VAL A 534 PRO A 535 SITE 2 AC7 8 LEU A 536 HOH A 701 HOH A 717 HOH A 720 SITE 1 AC8 3 GLU B 353 ARG B 394 LEU B 525 SITE 1 AC9 3 GLU B 323 TRP B 393 GOL B 603 SITE 1 AD1 9 GLU B 323 ILE B 326 GLY B 390 ARG B 394 SITE 2 AD1 9 PHE B 445 LYS B 449 GOL B 602 HOH B 732 SITE 3 AD1 9 HOH B 792 SITE 1 AD2 4 GLU B 444 LEU B 489 ALA B 493 HOH B 773 CRYST1 55.890 84.060 58.360 90.00 108.78 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017892 0.000000 0.006084 0.00000 SCALE2 0.000000 0.011896 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018099 0.00000